- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Insmed Inc+ Add to Watchlist
INSM:US17.6100 USD 0.5100 2.81%
As of 17:20:00 ET on 07/24/2014.
Company Profile for Insmed Inc (INSM)
Insmed, Inc. is a biopharmaceutical company focused on developing and commercializing novel, targeted inhaled therapies for patients with high unmet need battling serious orphan lung diseases.
Key Executives for Insmed Inc (INSM)
|William H Lewis "Will"President/CEO||Andrew T DrechslerChief Financial Officer|
|Matthew PaulsChief Commercial Officer||Christine A PellizzariSecretary/General Counsel|